RIGHTEST iFree 2 CGM in Pregnant Women With Diabetes Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 104 participants.

Also called NCT07889388

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 104 participants (planned count) (from the registry)
Sponsor
Bionime Corporation (from the registry)
Registry
  • NCT NCT07889388
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07889388. Allocation not applicable; no masking; primary purpose other. Start 2026-06-09 (actual); primary completion 2027-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
RIGHTEST iFree 2 CGM in Pregnant Women With Diabetes Study
Condition
Diabetes Mellitus, Type 1 Diabetes
Condition
Diabetes Mellitus, Type 2
Condition
Diabetes, Gestational
Intervention (Device)
RIGHTEST iFree 2 Continuous Glucose Monitoring System
Lead sponsor
Bionime Corporation (class: industry)

Record details

Record id
cardio:ct-nct07889388
Content hash
c1e06ad3ae3538fba1ee8da16c5e334fd0700d0c5bdca4b913635fa7762877a5